Vanda Pharmaceuticals Inc

VNDA 
(NASDAQ) 
 
$ 17.31 <%= Resources.Global.txtUp %>
Updated 22/04/2019
Change % 3.10% Stock price increasing
Change 0.52 Stock price increasing
Volume 499,513
High $ 17.41
Low $ 16.80
Open $ 16.80
ISIN
Prev close $ 16.79
# of shares 52.64M
Market cap 911.25M USD
Intraday

Market closed
Vanda Pharmaceuticals Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  17.31 4.0% Stock price increasing -1.6% Stock price decreasing -40.0% Stock price decreasing -13.5% Stock price decreasing 18.6% Stock price increasing
Powered by TradingView

News about Vanda Pharmaceuticals Inc

  • English
  • Regulatory news

Company profile

Vanda Pharmaceuticals Inc is a biopharmaceutical company which is engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant (VLY-686), VTR-297, and VQW-765.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 April 2019 23:44:03
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190410.2 - EUROWEB7 - 2019-04-24 00:44:03 - 2019-04-23 23:44:03 - 1000 - Website: OKAY